HTR1A and irritable bowel syndrome: However, these effects were prevented by 5-HT1A receptor antagonist NAN-190 hydrobromide (NAN-190), which indicate the involvement of 5-HT1A related signaling in treatment of brain-gut axis dysfunction in IBS-like animal models.